Knut R Madden

This inventor holds 15 USPTO granted patents and 12 published patent applications, plus 1 CIPO patent and 8 EPO patents, primarily in Molecular Cloning. Top assignees: Life Technologies Corporation, Invitrogen Corporation, Biogrammatics, Inc.. Active years: 2005-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Knut R Madden. Retrieved from https://idiyas.com/inventor/knut-r-madden

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 15 (Patent Applications = 12)

% Patents Active = 73.3

CIPO Patents = 1

EPO Patents = 8 (Patent Applications = 6)

Average Co-Inventor Count = 5.8

ph-index = 5

Forward Citations = 109(Granted Patents)

Company Filing History:

7 out of 1,900

Life Technologies Corporation

patents

5 out of 143

Invitrogen Corporation

Sloan-Kettering Institute for Cancer Research

patents

5. 1 out of 1

South Carolina Research Institute

patent

where one patent can have more than one assignee

Years Active: 2005-2025

Loading Chart...

Areas of Expertise:

Yeast Promoters

Protein Expression

Nucleic Acid Synthesis

Molecular Cloning

Recombinant Techniques

Topoisomerase Amplification

Recognition Sites

Seamless Cloning

Amplification Methods

Reagents

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12264319 - Yeast promotors for protein expression (2025-04-01),

2. 11555194 - Yeast promotors for protein expression (2023-01-17),

3. 10676750 - Yeast promoters for protein expression (2020-06-09),

4. 9309520 - Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites (2016-04-12),

5. 8945884 - Methods and compositions for synthesis of nucleic acid molecules using multiplerecognition sites (2015-02-03),

6. 8883991 - Methods and reagents for molecular cloning (2014-11-11),

7. 8338091 - Methods and compositions for seamless cloning of nucleic acid molecules (2012-12-25),

8. 8207318 - Methods and compositions for generating recombinant nucleic acid molecules (2012-06-26),

9. 8030066 - Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites (2011-10-04),

10. 7528241 - Methods and reagents for molecular cloning (2009-05-05),

11. 7244560 - Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites (2007-07-17),

12. 7198924 - Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites (2007-04-03),

13. 7078501 - Topoisomerase linker-mediated amplification methods (2006-07-18),

14. 7033801 - Compositions and methods for rapidly generating recombinant nucleic acid molecules (2006-04-25),

15. 6916632 - Methods and reagents for molecular cloning (2005-07-12),

Title: The Innovative Mind of Knut R Madden

Introduction: Knut R Madden, a talented inventor based in Carlsbad, CA, is known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Knut R Madden's most recent patents include a cutting-edge wearable device that revolutionizes the way individuals track their fitness goals and a unique software application designed to enhance cybersecurity measures for businesses.

Career Highlights: With a career spanning over two decades, Knut R Madden has established himself as a visionary in the tech industry. His innovative solutions have garnered widespread acclaim and have been instrumental in shaping the future of digital advancements.

Collaborations: Throughout his career, Knut R Madden has collaborated with leading tech companies and research institutions to bring his ideas to life. His ability to work seamlessly with teams of experts has resulted in the successful development of groundbreaking technologies.

Conclusion: Knut R Madden's passion for innovation and his relentless drive to push the boundaries of what is possible make him a true pioneer in the world of technology. His inventive spirit continues to inspire the next generation of inventors and solidify his legacy as a trailblazer in the industry.

Profile summary based on public USPTO records.